Friday

The Dow Jones Industrial Average teetered around the flat line as regulatory worries weighed on drug makers, while positive profit reports from technology companies helped limit the broader market's losses. Pharmaceutical stocks fell after the FDA delayed approval of a blood-thinning drug from European drug maker AstraZeneca, raising fears of greater hurdles in bringing new medications to market. Recent U.S. economic data have fueled hopes that the outlook is brightening gradually, though major market moves are not expected later this month. DJIA -7.34 Nasdaq +5.66 S&P 500 +1.04.